Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase EARLY_PHASE1 2Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 1

Conditions

Breast Neoplasms 161Neoplasms 95Prostatic Neoplasms 86Glioblastoma 76Multiple Myeloma 65Pancreatic Neoplasms 63Glioma 61Brain Neoplasms 56Lung Neoplasms 46Carcinoma, Hepatocellular 44Melanoma 43Head and Neck Neoplasms 43Recurrence 41Carcinoma, Non-Small-Cell Lung 41Leukemia, Myeloid, Acute 40Colorectal Neoplasms 38Squamous Cell Carcinoma of Head and Neck 35Ovarian Neoplasms 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 29Lymphoma, Non-Hodgkin 29Lymphoma 28Carcinoma, Renal Cell 28Polycystic Ovary Syndrome 27Stomach Neoplasms 24Hematologic Neoplasms 23Lymphoma, B-Cell 22Sarcoma 21Endometrial Neoplasms 20Uterine Cervical Neoplasms 19

Interventions

Bexarotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Aggression × Clear all
NCT00718770 2014-01-17

A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression

University of Colorado, Denver

Phase EARLY_PHASE1 Completed
10 enrolled 5 charts
Head & Neck

Aggression, Thyroid Neoplasms

NCT01417442 2011-08-16

BRAF V600E Mutations In Papillary Thyroid Carcinoma

Bezmialem Vakif University

Phase EARLY_PHASE1 Unknown
150 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Aggression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡